Gd-BOPTA
Gd-BOPTA Brand names, Gd-BOPTA Analogs
Gd-BOPTA Brand Names Mixture
- No information avaliable
Gd-BOPTA Chemical_Formula
C22H28GdN3O11
Gd-BOPTA RX_link
No information avaliable
Gd-BOPTA fda sheet
Gd-BOPTA msds (material safety sheet)
Gd-BOPTA Synthesis Reference
No information avaliable
Gd-BOPTA Molecular Weight
667.7 g/mol
Gd-BOPTA Melting Point
No information avaliable
Gd-BOPTA H2O Solubility
No information avaliable
Gd-BOPTA State
No information avaliable
Gd-BOPTA LogP
No information avaliable
Gd-BOPTA Dosage Forms
Liquid; Solution
Gd-BOPTA Indication
For magnetic resonance imaging (MRI) of the central nervous system in adults to visualize lesions with abnormal blood brain barrier or abnormal vascularity of the brain, spine, and associated tissues.
Gd-BOPTA Pharmacology
Gadobenate dimeglumine shares the pharmacokinetic properties of the ECF contrast agent gadopentetate dimeglumine; however, gadobenate differs in that is also selectively taken-up by hepatocytes and excreted via the bile (up to 5% of dose). The elimination half-life of gadobenate dimeglumine is approximately 1 hour. It is not metabolized.
Gd-BOPTA Absorption
No information avaliable
Gd-BOPTA side effects and Toxicity
No information avaliable
Gd-BOPTA Patient Information
No information avaliable
Gd-BOPTA Organisms Affected
Humans and other mammals
